Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance
Abstract Cancer remains one of the leading health threats globally, with therapeutic resistance being a long-standing challenge across chemotherapy, radiotherapy, targeted therapy, and immunotherapy. In recent years, the association between epigenetic modification abnormalities and therapeutic resis...
Saved in:
| Main Authors: | Jiawei Song, Ping Yang, Canting Chen, Weiqun Ding, Olivier Tillement, Hao Bai, Shuyu Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02266-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting ferroptosis: a promising avenue for ovarian cancer treatment
by: Xiaolan Wu, et al.
Published: (2025-06-01) -
Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris
by: Yuping Zhang, et al.
Published: (2025-05-01) -
Naphthalimide-polyamine conjugates: a promising avenue for targeted anticancer therapy
by: Zhiyong Tian, et al.
Published: (2025-12-01) -
New avenues of combating antibiotic resistance by targeting cryptic pockets
by: Yangyang Gao, et al.
Published: (2024-12-01) -
The Rho/MRTF-pirin axis: a promising target for overcoming melanoma drug resistance
by: Xiaoyan Chen, et al.
Published: (2025-07-01)